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Little is known of the age-dependent and long-term consequences of low exposure
levels of the herbicide and dopaminergic toxicant, paraquat. Thus, we assessed the
dose-dependent effects of paraquat using a typical short-term (3 week) exposure
procedure, followed by an assessment of the effects of chronic (16 weeks) exposure to
a very low dose (1/10th of what previously induced dopaminergic neuronal damage).
Short term paraquat treatment dose-dependently induced deficits in locomotion,
sucrose preference and Y-maze performance. Chronic low dose paraquat treatment
had a very different pattern of effects that were also dependent upon the age of
the animal: in direct contrast to the short-term effects, chronic low dose paraquat
increased sucrose consumption and reduced forced swim test (FST) immobility. Yet
these effects were age-dependent, only emerging in mice older than 13 months.
Likewise, Y-maze spontaneous alternations and home cage activity were dramatically
altered as a function of age and paraquat chronicity. In both the short and long-term
exposure studies, increased corticosterone and altered hippocampal glucocorticoid
receptor (GR) levels were induced by paraquat, but surprisingly these effects were
blunted in the older mice. Thus, paraquat clearly acts as a systemic stressor in
terms of corticoid signaling and behavioral outcomes, but that paradoxical effects
may occur with: (a) repeated exposure at; (b) very low doses; and (c) older age.
Collectively, these data raise the possibility that repeated “hits” with low doses of
paraquat in combination with aging processes might have promoted compensatory
outcomes.
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INTRODUCTION
Aging is associated with numerous neurobiological alterations over time, including elevations in
hypothalamic-pituitary-adrenal (HPA) axis activity, oxidative radicals, microglia activation and
blood-brain barrier (BBB) permeability, coupled with decreases in brain-derived neurotrophic
factor (BDNF; Pan, 2011; Jurgens and Johnson, 2012; Derecki et al., 2014; Lucke-Wold et al., 2014).
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It is well known that these changes can interact to promote
‘‘wear and tear’’ on the individual and modulate susceptibility
to environmental insults (Blau et al., 2012; Chapman et al.,
2012). Decreased cognitive ability and the emergence of
neuropsychological disturbances (e.g., anxiety and depression)
often coincide with these age-related biological alterations
(Balash et al., 2013; Yochim et al., 2013; Andreescu et al., 2015).
Moreover, aging (and the associated neuronal perturbations)
is an unequivocal risk factor for Parkinson’s disease, (PD)
Alzheimer’s disease (AD) and cerebral stroke (Miller et al., 2009;
Vasilevko et al., 2010).
Together with aging, exposure to environmental toxicants
likely shapes the evolution of brain pathology. In this regard,
paraquat is a commonly used fast acting herbicide that primarily
acts as an oxidative stress generator (Jiao et al., 2012; Baltazar
et al., 2014), but also has pro-inflammatory and anti-neurogenic
consequences (Bobyn et al., 2012; Desplats et al., 2012). Upon
entry into the brain, paraquat permeates cortical areas, as well
as the hippocampus, olfactory bulbs, and the substantia nigra
pars compacta (Peng et al., 2007). Not surprisingly, paraquat
can induce neurotoxicity and anti-oxidants may attenuate many
such outcomes (McCarthy et al., 2004; Peng et al., 2007;
Wang et al., 2011; He et al., 2012). In conjunction with such
aberrant biological changes, accumulating evidence suggests
that paraquat can also influence neurotransmission in stressor-
sensitive brain regions (e.g., prefrontal cortex, hippocampus and
locus coeruleus; Chanyachukul et al., 2004; Fernagut et al., 2007;
Litteljohn et al., 2008, 2009, 2011; Czerniczyniec et al., 2011;
Mitra et al., 2011). We posit that the emergence of paraquat’s
deleterious effects might be influenced by the age of the organism
upon exposure.
Relatively high doses (10 mg/kg) of paraquat promote the loss
of midbrain dopaminergic neurons, reminiscent of what occurs
in PD (Liou et al., 2001; Cicchetti et al., 2005; Mangano and
Hayley, 2009; Jiao et al., 2012). When considering the upper
concentrations of circulating paraquat (∼4.8 µg/ml) reported
to be associated with survival in cases of human poisoning
(Bertsias et al., 2004), together with the LD50 for the drug
(∼4 mg/kg in humans and 130 mg/kg in mice) and the
average body size and blood volume (male 76 kg, 5000 ml), the
‘‘typical’’ neurotoxic mouse dose is approaching the range of
what might be observed in cases of human poisoning. However,
nothing is known regarding the neuronal impact of much
lower doses of paraquat and with longer-term exposure. This is
important as this likely reflects the more typical situation among
pesticide workers and those living in close proximity to such
areas.
In the present investigation, we first conducted a relatively
short (3 week) paraquat dose-response study to assess HPA
functioning (corticosterone, hippocampal glucocorticoid
receptor (GR)), along with motor, cognitive and depressive-like
behaviors. We next assessed whether long-term exposure
(16 weeks) to a relatively low dose of paraquat (1 mg/kg)
in ‘‘younger’’ and ‘‘older’’ aged mice (beginning at 5 or
13 months of age, respectively) differentially affects biological
and behavioral stressor consequences. We additionally sought to
determine whether this paraquat regimen influenced expression
of the trophic factor, BDNF or the anti-oxidant related factor
[Nuclear factor erythroid 2-related factor 2 (Nrf2)]. It was
initially hypothesized that the short-term effects of paraquat
would be augmented by the long term exposure regimen.
Instead, we observed a highly complex profile of behavioral
and corticoid changes that suggest adaptive alterations occurred
with repeated low-dose exposure to the toxicant in aged
animals.
MATERIALS AND METHODS
Paraquat Dose Response
Animals and General Experimental Design
Briefly, 36 male C57/BL6 mice (Charles River, Laprarie, QC,
Canada) aged 3 months were single housed in standard (27 cm
× 21 cm × 14 cm) fully transparent polypropylene cages
and were acclimated to the Carleton University vivarium for
2 weeks. Mice were maintained on a 12-h light/dark cycle
in a temperature-controlled (21 degrees) environment with
ad libitum food and water. All experimental test protocols were
approved by the Carleton University Committee for Animal Care
and in very strict accordance with the guidelines outlined by the
Canadian Council for the Use and Care of Animals in Research.
All work was approved by these ethics boards. All behaviors were
performed between the hours of 8:00 am and 4:00 pm.
Injection Protocol
Animals received intraperitoneal (i.p) treatment of paraquat
[1,1′-dimethyl-4,4′-bipyridinium dichloride; Sigma Aldrich,
1 mg/kg (low dose) or 10 mg/kg (high dose)] or an
equivalent volume of physiological saline (Sigma; 12/group),
two times per week for three consecutive weeks. All injections
occurred in the morning beginning at 8:30 am. Mice were
sacrificed 5 days following the last paraquat or saline
injection via rapid decapitation 5 min following the last
behavioral test. A timeline for the study is depicted in
Figure 1.
Home Cage Locomotor Activity
Spontaneous home cage locomotor activity was measured
over a complete 12 h light/dark cycle using our Micromax
(MMx) infrared beam-break apparatus (Accuscan Instruments,
Columbus, OH, USA), as previously described (Litteljohn et al.,
2014). Total home cage locomotor activity is determined based
on the number of infrared beam-breaks an animal makes
based on 16 infrared wavelengths originating external to the
animal’s home cage. Briefly, following a 30 min acclimation
period in our behavioral testing room post nestlet removal,
measurements of 12-h home cage motor activity occurred once
at baseline, then again the evening of the 3rd, 5th and 6th
injection.
Sucrose Preference Test
In order to assess whether paraquat exposure at different doses
is associated with depressive-like non-motor behavior (very
common in PD patients), a sucrose preference test (SPT) was
conducted as a measure of anhedonia (Willner et al., 1987).
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FIGURE 1 | Schematic timeline for study 1. EPM, elevated plus maze; FST, forced Swim test; Inj, injection; MMx, micromax; OFT, open field test; PQ, paraquat (1 or
10 mg/kg); SAB, spontaneous alternation behavior; SPT, sucrose preference test.
All animals received baseline sucrose preference training for a
period of 5 days prior to the first injection and the SPT was
given 1 day following the 1st, 3rd and 6th injection. Briefly, on
baseline and testing days, animals were simultaneously exposed
to two 200 ml bottles containing sucrose solution or tap water
randomly placed approximately 5 cm apart from each other.
Animals received 5 days of baseline testing in which they
received 2 days of 2% sucrose solution followed by 3 days of a
1% sucrose solution post-acclimation. The amount of solution
consumed was determined based on bottle weights before and
24 h after placement. All solutions were made fresh each day.
Preference for the sucrose solution was calculated according to
the following formula: sucrose intake/(sucrose intake + water
intake) ∗ 100.
Spontaneous Alternation Behavior Y-maze
In order to assess working memory and executive function
impairment induced by low or high dose paraquat exposure, an
adapted version of the Y-maze was used, as outlined by Wall
and Messier (2001). The Y-maze consisted of three arms each
40 cm long × 3 cm wide enclosed by 13 cm high walls which
converged on an equilateral triangle at the center. Animals were
tested in this version of the Y-maze 2 days following the final
injection. Briefly, each animal was individually placed at random
in one of three enclosed arms for a total of 8 min. Alternate
arm returns (AAR), same arm returns (SAR), and spontaneous
alternation behavior (SAB) performance was recorded when an
animal had placed all four paws in the arm runway outside
of the center triangle. SARs were defined as when an animal
left a previously entered arm and then returned to the same
arm, with at least two paw entry into the center triangle and
without total entry into another arm. AAR was defined as when
an animal returned to a previously entered arm after four paw
entry into another arm (for example arm A to B and then back
to arm A). SAB performance was defined when an animal had
entered each arm with four paws in a sequential order without
returning to a previous arm (for example arm A to B followed
by arm B to C). For appropriate data analysis, scores were
expressed as percentages, in order to not bias any results affected
by the total number of arm entries. Thus the following equations
were used: %SAR = total number of same arm returns/total
number of arm entries ∗ 100%, AAR= alternate arm returns/total
arm entries ∗ 100, and %SAB = total number of sequential
alternations/total arm entries ∗ 100.
Open Field Test
The open field test (OFT) was used to assess the influence of
paraquat dose on anxiety-like behavior, as previously described
by Salmaso et al. (2016). The OFT was conducted 3 days
following the last paraquat/saline injection. Briefly, an open
white Plexiglas arena (26 × 48 cm) was used, and divided
into pre-defined zones (outer and inner/center). Each animal
was placed at random in one of four corners and behavior
was recorded for a period of 20 min. The amount of time
spent, distance traveled, speed, and freezing behavior in each
zone was recorded using our automated video-tracking system
(Any-Maze software, version 4.71). Anxiety-like behaviors
measured included the amount of time an animal spent in
either of the pre-defined zones, the amount of time spent
immobile in the zones and the frequencies of entry into
each zone. The arena was cleaned with 10% EtOH between
trials.
Elevated Plus Maze
To further measure anxiety-like behavior, the elevated plus
maze (EPM) was used, as previously described (Salmaso
et al., 2016). The EPM consists of four arms (24.8 cm
long × 7 cm wide) with two closed arms enclosed by 21 cm
high walls and elevated approximately 60 cm off the surface
of the floor. Three days following the last injection and 1 h
following the OFT, each animal was individually placed in
the center of the four-arm maze, and behavior was recorded
for a total of 6 min using Any-Maze software, version 4.71.
Anxiety-like behaviors measured included the percent time spent
in the open vs. closed arms during the first 5 min of the
test.
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Forced Swim Test
In order to further assess depressive-like effects (i.e., behavioral
despair) that may be induced by differential doses paraquat
exposure, a modified version of the Porsolt et al. (1977) forced
swim test was used (FST; as previously described by Litteljohn
et al., 2010). Mice were individually placed in a glass cylinder
20 cm in diameter that contained temperature controlled water
(25 ± 1◦C) at a depth of approximately 20 cm for a total of
6 min. Time immobile during the last 4 min of the test was
recorded on our camera and scored by an independent observer
blind to all experimental conditions. Immediately following the
task, animals were dried off, placed in their home cage, and
quickly transferred to necropsy where rapid decapitation was
performed.
Brain Extraction
Fiveminutes following the final behavioral task (between 8:30 am
and 11:00 am), mice were dried and tissue was collected for
western blot analysis. For rapidly decapitated animals, a chilled
microdissecting block that contained slots (0.5 mm apart) for
single edged razor blades was used. Brains were quickly excised
and the hippocampal region was micro-punched from coronal
brain sections in order to assess the effects of differential
doses of paraquat exposure on glucocorticoid and phosphor-GR
expression. The tissue was immediately frozen upon dissection
and stored at−80◦C until processing.
Western blot
Tissue punches collected from the hippocampus were used
to detect levels of brain the GR (∼86 kDa; Santa Cruz) and
the phospho-glucocorticoid receptor (pGR (Ser211), ∼95 kDa;
a marker of activated GR; Cell Signalling Technology).
Briefly hippocampal whole cell lysates were homogenized in
Radioimmunoprecipitation Assay (RIPA) buffer [50 mM Tris
(pH 8.0), 150 mM sodium chloride, 0.1% sodium dodecyl
sulfate (SDS), 0.5% sodium deoxycholate and 1% Triton X-100]
mixed with 1 tablet of Complete Mini EDTA-free protease
inhibitor (Roche Diagnostics, Laval, QC, USA, Cat #11 836
170 001) per 10 mL of buffer and then sonicated for 30 s
in ice cold water. The lysed cells were then centrifuged
at 5000 RPM with a table top microcentrifuge for 10 min
at 4◦C. The supernatant was then extracted and protein
concentration was determined using bicinchoninic acid (BCA)
method (Thermo Scientific, Cat #23227). Following protein
concentration determination supernatant was placed in 5×
loading buffer (containing; 5% glycerol, 5% β-mercaptoethanol,
3% SDS and 0.05% bromophenol blue) and the protein was
denatured when placed in a 5 min heating block at a temperature
of 105◦C. Following this step, samples were placed in a −20◦C
freezer until processing commenced.
On the first day of analysis, proteins were separated using
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Briefly the
SDS-PAGE gel (7.5%) containing the separating buffer (370 mM
Tris-base (pH 8.8), 3.5 mM SDS), and the stacking buffer
(124 mM Tris-base (pH 6.8), 3.5 mM SDS), were placed in
running buffer (25 mMTris-base, 190 mM glycine, 3.5 mM SDS)
and samples, along with the Precision Plus ProteinTM Standards
Dual Color (Bio-Rad, Hercules, CA, USA, Cat #161-0374), were
loaded into the Arcylamide gel (7.5%) for molecular weight
determination at 140 volts. After electrophoresis, proteins were
transferred for 1 h at 4◦C at 100 volts in transfer buffer solution
(25 mM Tris-base, 192 mMGlycine, 20% methanol), onto PVDF
(Bio-Rad, Cat #162-0177). Thereafter, membranes were dried
overnight.
In order to determine total protein, after a brief methanol
rinse (5 s), membranes were incubated in a reversible stain,
REVERTr (Li-COR Biotechnology) for a period of 5 min
followed by placement into a wash solution (6.7% Glacial
Acetic Acid, 30% Methanol, in water) two times 2 min each.
Membranes were then quickly rinsed with distilled water and
imaged on a LI-COROdyssey imaging system on the 700 channel
for an exposure period of 2 min. Membranes were rinsed
immediately post imaging in tris buffered saline (TBS; pH 7.5
(2 × 5 min)) buffer and then placed in blocking solution
(0.5% fish gelatin (Sigma) in TBS) for 90 min. After blocking,
membranes were incubated in either a rabbit anti-GR primary
antibody (1:500) or rabbit anti-pGR (1:1000), as well as mouse
anti-actin (ThermoFisher) for a period of 60 min in 0.05% fish
gelatin in TBS with 0.1% tween. Any unbound antibody was
removed using 15 mL of TBS-T/membrane at room temperature
four times 5 min each. Membranes were then incubated for
1 h in infrared conjugate directed against the species the
primary antibody was raised in (rabbit 800, LI-COR) at a
concentration of 1:20,000 in 0.5% fish gelatin solution containing
0.2% tween and 0.01%SDS. Membranes were then washed
in TBS-T (4 × 5 min) followed by 2 × 5 min washes in
TBS and read on the LI-COR Odyssey system at 800 nm for
6 min.
Corticosterone (CORT) assay
Differences in CORT levels were obtained with an ELISA CORT
determination assay (Corticosterone #900-097, Lot# D1260724)
using trunk blood collected immediately after decapitation. All
blood samples were collected in EDTA-coated Eppendorf tubes,
after which they were spun for 20 min at 4◦C (20,000 g). After
serum collection samples were immediately frozen and stored
at −80◦C. CORT determination was then performed using our
microplate reader and quantified.
Aging and Chronic Low-Dose Paraquat
Exposure
Animals
Forty-two male C57/BL6J mice (Jackson Laboratories, Bar
Harbor, ME, USA) aged 5 months (operationally defined as
‘‘younger’’ cohort) and 13 months (operationally defined as
(‘‘older’’ cohort) were housed in standard (27 cm × 21 cm
× 14 cm) fully transparent polypropylene cages. The entire
study lasted 4 months; thus, mice were either 9 months
(‘‘younger’’ cohort; 5–9 months) or 17 months (‘‘older’’ cohort;
13–17 months) of age at the time of sacrifice. All mice were
initially obtained at 6–8 weeks of age and singly housed in
the same conditions as Study 1. All animal procedures were
performed in accordance with Carleton University animal care
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FIGURE 2 | Schematic timeline for study 2. FST, forced swim test; MMx, micromax; SAB, spontaneous alternation behavior; SPT, sucrose preference test.
committee’s regulations. A timeline for this study can be seen in
Figure 2.
Treatments and General Procedures
Animals received i.p. injections of paraquat (1 mg/kg) or
an equivalent volume of physiological saline once per week
for 16 consecutive weeks (n = 10–12/group). This dose was
based on previous studies demonstrating no peripheral toxic
effects and is believed to be below the concentration required
to produce degeneration of dopamine neurons (McCormack
et al., 2002; Yin et al., 2011). Indeed, our primary goal was
to evaluate the consequences of chronic low dose oxidative
stress exposure in the context of advancing age and not to
model the frank neurodegenerative effects seen in previous PD
models.
Behavioral Tests
Home Cage Locomotor Activity
Spontaneous locomotor activity was measured over a complete
24 h light/dark cycle using our Micromax (MMx) infrared
beam-break apparatus (Accuscan Instruments, Columbus, OH,
USA), as described above. Briefly, following a 30-min acclimation
period in our behavioral testing room, measurements of
locomotor activity occurred 1 h after paraquat or saline exposure
one time per month during the 16-week paradigm (i.e., weeks 3,
7, 11 and 15).
Two-Trial Y-maze
In order to test spatial memory retention performance, the
discreet two-trial Y-maze was used (Dellu et al., 2000). During
this task, animals were first individually placed into one of
two arms in the Y-maze for a period of 5 min, with the
third arm blocked by a divider at random. Following a 30-min
interval, the divider was removed and animals were allowed
to freely explore all three arms of the maze for another
5 min. In order to analyze the task, the time spent exploring
the novel vs. familiar arms was calculated as the ratio (time
spent in the novel arm/(time spent in the novel + adjacent
arms)) × 100. Time spent in novel arms is believed to be a
measure of spatial memory and retention and was expressed
in percentages in order to not bias any locomotor results
(calculated as the number of arm entries during the acquisition
trial). This task was held in our behavior room on week
11 of the behavioral paradigm immediately after locomotor
measurements were taken and 1 day after paraquat or saline
injection. All arms were cleaned with 10% ethanol between
trials.
Spontaneous Alternation Behavior Y-maze
In order to test for working memory performance, the SAB
Y-maze was used as described in Study 1. This version of the
Y-maze was performed onWeek 15 immediately after locomotor
testing. All arms were cleaned with 10% ethanol between trials.
All trials were recorded on our camera and later scored by an
observer who was naïve to the study.
Sucrose Preference Test
In order to assess whether or not low-dose chronic paraquat
exposure is associated with depressive-like behaviors, a SPT was
administered as a measure of anhedonia, as described in study 1.
Briefly, every other week, 1 day following paraquat or saline
injections mice were simultaneously exposed to two 200 ml
bottles containing 1% sucrose solution or tap water randomly
placed approximately 5 cm apart from each other. All solutions
were made fresh each day and bottle weight measurements
were taken before and 12 h after overnight testing in order to
determine sucrose preference.
Forced Swim Test
In order to assess depressive-like effects (i.e., behavioral
despair) that may be induced by chronic paraquat exposure,
a modified version of the Porsolt et al. (1977) FST was
used as described in Study 1. Immediately following the task,
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animals were dried off and placed in their home cage and
quickly transferred to necropsy where rapid decapitation was
performed.
Biological Outcome Measures
Brain Dissection and Plasma Collection
All mice were sacrificed 5 days following the last paraquat
or saline injection. Five minutes after the final behavioral
task (between 9:00 am and 11:00 am), mice were rapidly
decapitated and brains and trunk blood were collected (as
described in Study 1) in order to evaluate plasma corticosterone
and hippocampal protein expression (i.e., phosphorylated
glucocorticoid receptors (pGR), BDNF and Nrf2 via
radioimmunoassay and Western blot analyses, respectively).
Tissue was immediately frozen and stored at −80◦C until
processing. Trunk blood was centrifuged at 3600 rpm (8 min)
in order to collect plasma and was stored at −80◦C until
corticosterone determination.
Corticosterone Determination
In order to determine concentration levels of corticosterone in
plasma, a commercial radioimmunoassay kit (ICN Biomedicals
Inc., USA) was used. Assays were performed in a single run to
prevent inter-assay variability; intra-assay variability was<10%.
Western Blots
Tissue samples were collected from the hippocampus to detect
levels of mature BDNF (∼14 kDa), Nrf2 (∼68 kDa) and pGR
(∼95 kDa) as previously described (Griesbach et al., 2012).
Primary antibodies for BDNF (1:300, Abcam), Nrf2 (1:500,
Abcam) and pGR (1:500, Cell Signaling Technology) were used
and β-actin (∼42 kDa; 1:10,000, Sigma) was applied as a loading
control. Protein determination and Western blot procedures for
hippocampus whole cell lysates were carried in a procedure
identical to study 1 (i.e., from tissue homogenization—protein
PVDF membrane transfer).
Following transfer, membranes were blocked for 1 h with
gentle shaking in a solution of non-fat dry milk (5% w/v)
dissolved in TBS-T buffer (10 mM Tris-base (pH 8.0), 150 mM
sodium chloride, 0.5% Tween-20). The membranes were then
incubated with a rabbit anti-BDNF, rabbit anti-Nrf2 and rabbit
anti-phospho GR primary antibody diluted in blocking solution
at room temperature for 1 h. Any unbound antibody was
removed using three 10 min washes of 15 mL TBS-T at
room temperature. Membranes were incubated on a shaker for
1 h at room temperature with HRP (horseradish peroxidase)
conjugated anti-rabbit (1:5000) secondary antibody and washed
again with TBS-T. BDNF, Nrf2 and pGR were then visualized
using Western Lightning Plus chemiluminescent substrate
(Perkin Elmer, Waltham, MA, USA, Cat #.NEL102001EA)
and by exposure to Kodak X-OMAT film. The molecular
weights of proteins were estimated using Precision Plus Protein
Kaleidoscope Standards (Bio-Rad, Hercules, CA, USA). Protein
bands were quantified by densitometry using AlphaEase software
(AlphaEase FC V.3.1.3., Alpha Innotech Co., San Leandro, CA,
USA) and normalized to actin.
Data Analysis
For Study 1, all data was analyzed using a one-way analysis of
variance (ANOVA) for paraquat dose treatment comparisons,
with significant interactions further analyzed by means of
Fisher’s planned comparisons (p < 0.05). For Study 2, all
data was analyzed using a 2 (paraquat vs. saline treatment)
by 2 (younger vs. older cohorts) two-way ANOVA design
followed by Fisher’s planned comparisons (p < 0.05) where
appropriate. Additionally, for both studies, the analyses of SPT
and total home cage locomotor activity, was completed using
appropriate repeated measures ANOVA’s conducted with Time
as the 3rd independent variable followed by post hoc analysis.
Data is presented in the form of mean ± standard error mean
(mean ± SEM). All data was analyzed using the statistical
software StatView (version 6.0) and differences were considered
statistically significant when p< 0.05.
RESULTS
Study 1: Paraquat Dose-Response
Spontaneous Home Cage Locomotor Activity
The one-way repeated measures ANOVA conducted to compare
the effect of paraquat dose on total home cage activity after three,
five and six injections demonstrated that paraquat reduced home
cage activity levels (F(2,33) = 4.631, n = 12/group, p < 0.05).
The follow-up comparisons clearly revealed that the locomotor
reduction in the beam-breaks was confined to mice that received
the high dose of paraquat (p< 0.05; Figure 3).
Working Memory in a Spontaneous Alternation
Y-maze
A significant main effect was evident for paraquat treatment
with regard to percent spontaneous alternations (F(2,33) = 9.53,
n = 12/group, p < 0.001). Indeed, paraquat did appear to
dose-dependently disrupt working memory, as indicated by the
reduction of alternations provoked by the high paraquat dose
group (p< 0.05; Figure 3).
Anxiety-Like Behavior in the Open Field and Elevated
Plus Maze Tests
No dose-dependent effects of paraquat treatment were evident
on anxiety-like behavior measures using the elevated plus maze
or the OFT.
Depressive-Like Behaviors in Sucrose Preference
and Forced Swim Tests
All animals included showed an at least 70% preference for
sucrose over water by the end of the baseline period. The results
of the repeated measures ANOVA analyses indicated that there
was no significant effect of paraquat at either of the doses
administered.
Paraquat however, significantly affected FST performance
F(2,32) = 4.25, n = 12/group, p < 0.05). Interestingly, both
the low and high doses of paraquat significantly increased
time immobile, relative to controls (p < 0.05; Figure 4).
Thus, paraquat appears to differentially affect tests that tap
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FIGURE 3 | Dose-dependent effects of short term paraquat treatment on
home cage activity and Y-maze performance. As depicted in (A), the higher
dose of paraquat (PQ-High; 10 mg/kg; blue line) significantly reduced home
cage activity, relative to mice treated with the low toxicant dose (PQ-Low;
1 mg/kg; black line) or saline (red line). As depicted in (B), the high paraquat
dose likewise reduced the number of spontaneous alternations in a Y-maze
task, suggesting some degree of cognitive deficit. ∗p < 0.05, relative to saline
or low-dose paraquat treated mice.
into anhedonic (sucrose preference) vs. ‘‘learned helplessness’’
(forced swim).
Plasma Corticosterone
As shown in Figure 5, paraquat treatment influenced
plasma corticosterone levels (F(2,15) = 5.32, n = 9/group,
p < 0.01). The follow-up comparisons indicated that again
paraquat dose-dependently increased plasma corticosterone
concentrations, such that only the high dose was effective in this
regard (p< 0.05).
Hippocampal GR Levels
Paraquat exposure significantly influenced hippocampal levels
of GR (F(2,15) = 4.51, n = 9/group, p < 0.05) but not pGR
F(2,15) = 0.263, p > 0.05). Specifically, as shown in Figure 5, and
confirmed by follow-up comparisons, the high dose of paraquat
reduced hippocampal GR levels, relative to saline or low dose
paraquat treatment (p < 0.05). Similarly, the ratio of pGR to GR
was significantly affected by paraquat F(2,15) = 4.92, p> 0.05, and
this effect was restricted to an increase provoked by the high dose
(p< 0.05). Yet, it was clear that overall GR reduction was driving
this effect.
FIGURE 4 | Dose-dependent effects of short term paraquat exposure on
force swim immobility but not sucrose preference. As shown in (A), short term
low dose (PQ-Low; 1 mg/kg) or high dose (PQ-High; 10 mg/kg) paraquat
exposure did not influence sucrose preference at any time point (n.s = not
significant). As shown in (B), both the 1 and 10 mg/kg doses of paraquat
effectively increased the time immobile in a forced swim test. ∗p < 0.05,
relative to saline treated mice.
Study 2: Age-Dependent Effects of Chronic
Low-Dose Paraquat Exposure
Spontaneous Home Cage Locomotor Activity
Overall, results of the repeated measures two-way ANOVA
demonstrated only age-related differences in home cage
locomotor activity, with older mice (age 13–17 months)
displaying lower home cage activity levels (F(1,32) = 4.81,
n = 9–11/group, p < 0.05), compared to the younger cohort
(age 5–9 months; Figure 6). Exposure to paraquat treatment did
not significantly influence home cage locomotor activity in either
group.
Working Memory in a Spontaneous Alternation
Y-maze
The paraquat treatment group showed a significant main effect
in the percentage of spontaneous alternations (F(1,32) = 5.29,
n = 7–10/group, p < 0.05), with paraquat-treated animals
making more spontaneous alternations. Although no significant
main effect of Age or Age by Paraquat treatment interaction
was observed, it was clear that a reduction in the number
of spontaneous alternations was most apparent in the saline
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FIGURE 5 | Dose-dependent effects of short term paraquat administration on plasma corticosterone and hippocampal glucocorticoid receptor (GR) levels. As shown
in (A), the higher paraquat dose (PQ High; 10 mg/kg) relative to the lower dose (PQ Low; 1 mg/kg) significantly increased plasma corticosterone levels. At the same
time, paraquat did not increase levels of the active form of GR (pGR; B), but the higher toxicant dose did increase levels of pGR relative to GR (C). However, given
that the higher paraquat dose decreased levels of total GR (D) within the hippocampus, pGR levels were unaltered by the toxicant. ∗p < 0.05, relative to saline and
low dose paraquat treated mice.
treated mice who began the injection regimen at 13 months
(Figure 6). From another perspective, as shown in Figure 4,
FIGURE 6 | Effect of long-term (low dose) paraquat exposure and age on
locomotor activity and spontaneous alternation version of a Y-maze.
Irrespective of paraquat treatment, the older cohort of mice (13–17 months)
showed reduced total home-cage locomotor activity (A) in comparison to the
younger cohort (5–9 months). ∗p < 0.05 relative to the younger cohort
(5–9 months; data presented collapsed over paraquat treatment for better
representation). In the absence of a significant age effect, paraquat treatment
increased the number of spontaneous alternations in a Y-maze (B). Yet,
although not significant, the magnitude of this effect appears greater in the
aged mice. Dotted line indicates chance performance. +p < 0.05 relative to
saline treated mice (collapsed over age).
paraquat appeared to enhance spontaneous alternations
in the older aged animals. In all cases, except the saline
treated older mice, performance was statistically above
chance (50%).
Spatial Memory in a Two-Trial Y-maze
No significant main effects, or interaction with regard to Age or
Paraquat treatment was observed on % time spent in novel arm
in the two-trial Y-maze cognitive task.
Anhedonia in a Sucrose Preference Test
All animals showed an at least 70% preference for sucrose
over water by the end of the baseline period. While a
relatively long interval elapsed between sucrose preference
testing sessions, preference was nevertheless maintained across
all groups 2 weeks after baseline measurements. The results
of the repeated measures ANOVA analyses indicated that
there was a significant Age by Paraquat interaction in sucrose
preference scores (F(1,28) = 8.54, n = 7–9/group, p < 0.01).
Specifically, as shown in Figure 7, oldermice exposed to paraquat
beginning at 13 months had greater sucrose preference than
their age-matched counterparts administered saline (p < 0.05).
No such difference in sucrose preference was observed among
the middle-aged animals as a function of paraquat exposure
(Figure 7).
Forced Swim Test Performance
A two-way ANOVA revealed a significant Age by Paraquat
treatment interaction on the percent of time animals spent
immobile (F(1,32) = 4.16, n = 7–11/group, p < 0.01). As
shown in Figure 7 and confirmed by Fisher’s planned
comparisons, mice from the older cohort (13–17 months)
administered paraquat displayed a significant reduction in time
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FIGURE 7 | Effect of long-term (low dose) paraquat treatment and age on sucrose preference and forced swim performance. As depicted in (A), paraquat treatment
augmented sucrose preference in the older cohort (13–17 months) relative to the remaining three groups. In contrast, the younger cohort of mice (5–9 months) that
received paraquat (black line) did not differ from their saline treated counterparts (dotted black line) or saline treated aged animals (green line). Time spent immobile in
the FST is shown in (B). The older cohort of mice exposed to the low dose, chronic paraquat regimen (right black bar) spent significantly less time immobile than the
other three groups. ∗p < 0.05 relative to all other groups.
immobile in comparison with the saline-treated younger cohort
(5–9 months; p < 0.01) and same age counterparts (p < 0.05),
FIGURE 8 | Plasma corticosterone and hippocampal pGR protein as a
function of age and long-term (low dose) paraquat treatment. As shown in (A),
the older cohort (13–17 months) displayed elevated corticosterone levels
(collapsed over paraquat treatment). Paraquat treatment elevated corticoid
levels; but interestingly, this effect was restricted to the younger cohort
(5–9 months). ∗p < 0.05 relative to the saline treated younger cohort. As
displayed in (B), paraquat robustly increased hippocampal protein levels of
pGR in the younger cohort in comparison to age matched saline treated mice,
however, it significantly reduced levels in mice from the older cohort, relative to
their saline injected counterparts. ∗p < 0.05 relative to saline treated mice
from the younger cohort, +p < 0.05 relative to saline treated mice form the
older cohort.
as well as in relation to younger mice exposed to paraquat
(p< 0.05).
Plasma Corticosterone
As shown in Figure 8, a significant Age by Paraquat treatment
interaction was evident with respect to plasma corticosterone
levels (F(1,33) = 5.69, n = 7–11/group, p < 0.05). The follow-up
comparisons indicated that corticosterone concentrations were
significantly increased by paraquat treatment in the younger
mice (p < 0.05), whereas no such effects were apparent in
the older cohort. However, age itself had a dramatic effect on
corticosterone with aged animals overall showing a marked
elevation of the hormone that exceeded that of the younger mice
(p< 0.01).
Hippocampal pGR Levels
Western blot analysis of hippocampal pGR protein levels
revealed a significant Age by Paraquat treatment interaction
(F(1,26) = 20.19, n = 6–9/group, p < 0.01; Figure 8). Follow-up
with Fisher’s planned comparisons revealed that mice exposed
to the low-dose paraquat treatment in the younger cohort had
significantly higher hippocampal pGR protein levels than their
saline exposed counterparts (p < 0.01). Moreover, as shown in
Figure 8, age itself was associated with a rise in pGR expression,
yet paraquat treatment in the older cohort actually reduced this
elevation (p< 0.05).
Additional Western blot analyses of BDNF and Nrf2 levels
within the hippocampus yielded no significant differences
between any of the treatment groups. However, we should
mention that our Nrf2 antibody was designed to detect the
expected molecular weight of 68 kDa; yet it was recently reported
that the protein yielded a band with a molecular weight of
95–110 kDa (Lau et al., 2013). That said, using our procedures,
we reliably detected a 68 kDa band with negligible higher weight
signals.
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DISCUSSION
Given that paraquat is essentially an oxidative stress generator, it
is not surprising that extensive brain changes in oxidative and
inflammatory signaling factors have also been reported, along
with a variety of behavioral disturbances (Litteljohn et al., 2009;
Mangano et al., 2011). However, these studies were conducted
over a relatively short period of time in young animals and
involved high doses of paraquat that can kill dopaminergic
neurons (McCormack et al., 2006; Mangano et al., 2011). In
contrast, the present investigation assessed the effects of a
substantially lower paraquat dose (1 mg/kg; 1/10th of what we
use in our Parkinsonian animal model studies; e.g., Mangano
and Hayley, 2009). Moreover, we used older mice (either 5 or
13 months of age at the beginning of the present study, compared
to 2–3 month-old animals in previous studies) and longer-term
exposure (4 months compared to previous studies involving
3 weeks of paraquat treatment, e.g., Mangano and Hayley,
2009; Mangano et al., 2011). We were particularly interested
in whether any behavioral and biological (HPA functioning)
indices of stressor reactivity effects would be augmented over
time in the older animals (given that aging itself is associated with
cumulative oxidative and inflammatory effects; Vida et al., 2014).
While short-term (3 weeks) paraquat treatment had
dose-dependent behavioral and hormonal effects similar to
that of traditional stressors, long-term (4 months) treatment
with low doses of paraquat (that themselves have few short-term
effects) provoked a complex pattern of behavioral and hormonal
changes that were quite unexpected. In fact, the chronic low-dose
paraquat treatment didn’t affect home cage activity, but had
effects in the Y-maze, forced swim and SPTs that were the
opposite of what one might predict, based on the known
deleterious effects of the toxicant. These animals also displayed
marked changes in HPA functioning, suggesting that a general
stress response was induced by both paraquat and aging. These
findings raise the possibility that adaptive responses were
engendered by paraquat, or essentially that the repeated low
levels of oxidative stress provoked by the toxicant might have
triggered adaptive cellular stress pathways.
It is well known that certain toxicants can have U-shaped or
inverted U-shaped dose-response relationships that follow the
concept of hormesis, wherein higher doses have toxic effects
but lower concentrations can actually impart beneficial actions
(Wang, 2012). For instance, it was previously reported that low
concentrations of paraquat could promote an adaptive stress
response to increase survival of knockdown parkin flies (a genetic
insect model of Parkinsonism; Mattson, 2008; Bonilla-Ramirez
et al., 2013). Yet, no other such reports exist in other model
organisms, and it is entirely unknown as to whether hormetic
effects might be observed at the behavioral or systems level
with repeated in vivo injection of the herbicide in rodents. It
is of interest that repeated mild stress challenges have been
reported to induce anti-aging effects that were posited to stem
from changes in proteasomal and anti-oxidant functions (Rattan
et al., 2004; Mattson, 2014). Importantly, however, our attempt
to link possibly ‘‘adaptive’’ trophic (BDNF) and anti-oxidant
(Nrf2) hippocampal factors to the observed paraquat and aging
responses was unsuccessful, as these factors were unaffected by
any of the treatments (data not shown).
While the high dose of paraquat reduced hippocampal GR,
neither the high nor low doses affected its phosphorylated active
form, pGR, in the short term study. In contrast, the long-term
low dose paraquat treatment increased hippocampal pGR in
the ‘‘younger’’ 5–9 month old mice of the chronic study. Most
interesting however, the long-term low-dose paraquat treatment
reduced hippocampal pGR in the ‘‘older’’ 13–17 month mice.
Conceivably, the herbicide might influence negative feedback
aspects of HPA functioning in mice that received the ‘‘added
hit’’ of pesticide exposure in the context of older age. Indeed,
plasma corticosterone levels and hippocampal pGR expression
were increased by both paraquat and aging. However, most
intriguingly, the combination of older age and paraquat reduced
hippocampal pGR expression back to basal levels.
It is possible that such GR changes could reflect compensatory
or adaptive processes that were engaged (possibily in response
to chronically elevated corticosterone levels). This raises the
possibility that with age the normal HPA genetic regulatory
apparatus might be altered which in turn, could either facilitate
or hinder adaptive homeostatic processes. Such processes could
essentially moderate corticosterone secretion in an attempt to
try and restore homeostasis. It is also possible that while the
combined paraquat + aging variables did not further increase the
overall magnitude of the hormonal response (possibly resulting
from a ceiling effect, given that the levels were exceedingly
high; approaching 60 ug/dl), the kinetics of the response might
have been altered. Yet, we cannot definitively speak to the
time-course for variations in the hormone given the single
sampling time.
The present findings are in agreement with our proposition
that paraquat acts as a systemic stressor, much the same
as pro-inflammatory cytokines (Rudyk et al., 2015), and
that its HPA effects could contribute to depressive or other
co-morbid features that are often evident in neurodegenerative
diseases, such as PD. Indeed, the observed paraquat-induced
dose-dependent corticosterone elevation, coupled with the
decrease in total hippocampal GR is consistent with what has
been observed with psychological stressor exposure (Füchsl and
Reber, 2016).
Interestingly, we previously found that when co-applied with
a psychological stressor, paraquat did not further augment
corticosterone or neurochemical activity (Rudyk et al., 2015).
This suggests that the toxicant and stressor do not synergistically
or even additively reinforce each other’s actions, and while they
may affect similar biological outcomes, they may do so through
differentmechanisms. Indeed, the oxidative stress factors, such as
nitric oxide and superoxide, typically provoked by paraquat have
been associated with HPA activation (Lee et al., 2013), but such
factors are generally not induced bymost stressors unless they are
extremely severe and prolonged (e.g., 7 h or restraint or repeated
restraint for weeks, compared to a typical 20–60 min acute
session; García-Fernández et al., 2012; Lee et al., 2012; Moretti
et al., 2013). Thus, we hypothesize that paraquat likely provokes
HPA activation through its oxidative stress effects within the
brain, whereas more psychologically relevant stressors signal
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through more classically prescribed stress pathways (e.g., by
affecting limbic neurotransmission).
Overall, the present study indicates that paraquat and age can
influence stress hormone and hippocampal functioning, as well
as induce a range of behavioral adaptations over long periods of
time. Some of the unexpected effects of paraquat are clearly in
line with the perspective that repeated low-dose oxidative stress
factors could promote adaptive responses over time. Although
BDNF and Nrf2 were not affected, future studies should focus
on other potential endogenous factors that might underlie
paraquat-induced adaptive responses, including time-dependent
variations in heat shock proteins or other molecular chaperones
that contribute to cellular homeostasis. Whatever the case, the
present data could have important implications for mechanisms
of action of chronic oxidative stressors and might also help
inform environmental policies regarding toxicant levels of
exposure and age-dependent health risks.
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